RxDoctor Payments Data

Raman Malhotra, MD

Sleep Medicine · Saint Louis, MONPI 1215018452

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (42.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Axsome Therapeutics, Inc. at 58.1% of the total. Reporting peaked in 2024 at $4,620 and has fallen 72.7% since, to $1,262 in 2025. Among sleep medicine clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,393in general payments, 2019–2025

Across 35 payments — averaging $211.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axsome Therapeutics, Inc.$4K
  • Inspire Medical Systems, Inc.$3K
  • Jazz Pharmaceuticals Inc.$192
  • Harmony Biosciences LLC$140
  • Fisher & Paykel Healthcare Inc$56
  • Resmed Corp$47
  • plus $18 from 1 others

What the payments were for

  • Consulting fees$3,12542%
  • Travel & lodging$2,47433%
  • Food & beverage$1,60222%
  • Education$1923%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,393 in reported general payments places this provider in the 95th percentile of 33 sleep medicine providers in Missouri.

See all sleep medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$111,600
Medicare patients
326
Services billed
563

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XywavSodium,calcium,mag,pot Oxybate12$244,190
XyremSodium Oxybate12$243,817
NeuproRotigotine15$22,995
SunosiSolriamfetol Hcl17$15,276
BelsomraSuvorexant13$5,644
OxycontinOxycodone Hcl13$4,213
Modafinil46$3,665
Gabapentin106$2,078
Zolpidem Tartrate ErZolpidem Tartrate31$1,667
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine53$1,665
Clonazepam60$903
Methylphenidate ErMethylphenidate Hcl15$898
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine27$670
Ropinirole Hcl35$587
Pramipexole DihydrochloridePramipexole Di-Hcl21$487

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Axsome Therapeutics, Inc.Sunosi$4,294$15,27617 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 33 sleep medicine providers in Missouri.

Other sleep medicine in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →